Maintenance in progress

novo nordisk confirmed unauthorized access to internal systems and extraction of non-public data including limited patient trial information. the group fulcrumsec separately claimed extraction of over one terabyte including source code, unreleased drug data, clinical trial data, and internal ai models, with a 25 million dollar extortion demand. the inclusion of ai model weights in the claimed theft is structurally notable: pharmaceutical ai models trained on proprietary drug discovery data represent a new category of high-value target in ransomware operations.

pharmaceutical sector and security disclosure